1. Home
  2. BNR vs MGRM Comparison

BNR vs MGRM Comparison

Compare BNR & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • MGRM
  • Stock Information
  • Founded
  • BNR 2014
  • MGRM 2016
  • Country
  • BNR China
  • MGRM United States
  • Employees
  • BNR N/A
  • MGRM N/A
  • Industry
  • BNR Medical Specialities
  • MGRM Medical/Dental Instruments
  • Sector
  • BNR Health Care
  • MGRM Health Care
  • Exchange
  • BNR Nasdaq
  • MGRM Nasdaq
  • Market Cap
  • BNR 73.5M
  • MGRM 66.9M
  • IPO Year
  • BNR 2020
  • MGRM N/A
  • Fundamental
  • Price
  • BNR N/A
  • MGRM $2.59
  • Analyst Decision
  • BNR
  • MGRM Strong Buy
  • Analyst Count
  • BNR 0
  • MGRM 1
  • Target Price
  • BNR N/A
  • MGRM $4.00
  • AVG Volume (30 Days)
  • BNR 15.0K
  • MGRM 89.0K
  • Earning Date
  • BNR 12-31-2024
  • MGRM 11-14-2024
  • Dividend Yield
  • BNR N/A
  • MGRM N/A
  • EPS Growth
  • BNR N/A
  • MGRM N/A
  • EPS
  • BNR N/A
  • MGRM N/A
  • Revenue
  • BNR $72,832,704.00
  • MGRM $364,999.00
  • Revenue This Year
  • BNR $52.90
  • MGRM N/A
  • Revenue Next Year
  • BNR $48.35
  • MGRM N/A
  • P/E Ratio
  • BNR N/A
  • MGRM N/A
  • Revenue Growth
  • BNR N/A
  • MGRM N/A
  • 52 Week Low
  • BNR $2.62
  • MGRM $1.53
  • 52 Week High
  • BNR $9.99
  • MGRM $4.90
  • Technical
  • Relative Strength Index (RSI)
  • BNR 57.52
  • MGRM 54.26
  • Support Level
  • BNR $5.96
  • MGRM $2.41
  • Resistance Level
  • BNR $7.14
  • MGRM $2.95
  • Average True Range (ATR)
  • BNR 0.50
  • MGRM 0.20
  • MACD
  • BNR -0.13
  • MGRM 0.00
  • Stochastic Oscillator
  • BNR 35.76
  • MGRM 49.82

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About MGRM Monogram Orthopaedics Inc.

Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.

Share on Social Networks: